Profile data is unavailable for this security.
About the company
Alaunos Therapeutics, Inc. is a clinical-stage oncology-focused cell therapy company. The Company is focused on exploring strategic alternatives, including, but not limited to, an acquisition, merger, reverse merger, sale of assets, strategic partnerships, capital raises or other transactions. Separately, the Company is evaluating several potential in-licensing opportunities in obesity, oncology and virology.
- Revenue in USD (TTM)6.00k
- Net income in USD-26.77m
- Incorporated2005
- Employees1.00
- LocationAlaunos Therapeutics Inc2617 Bissonnet St, Suite 225HOUSTON 77005United StatesUSA
- Phone+1 (617) 259-1970
- Fax+1 (617) 241-2855
- Websitehttps://alaunos.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nascent Biotech Inc | 0.00 | -2.09m | 16.80m | -- | -- | 550.02 | -- | -- | -0.0147 | -0.0147 | 0.00 | 0.0002 | 0.00 | -- | -- | -- | -346.80 | -815.53 | -- | -- | -- | -- | -- | -548.75 | -- | -- | 0.8045 | -- | -100.00 | -- | -495.46 | -- | -- | -- |
| Aytu Biopharma Inc | 93.76m | -13.68m | 17.15m | 150.00 | -- | 0.5572 | -- | 0.1829 | -2.65 | -2.65 | 18.21 | 5.53 | 0.6792 | 2.42 | 2.93 | 625,053.30 | -9.91 | -33.56 | -25.58 | -52.81 | 65.32 | 56.89 | -14.60 | -73.81 | 0.6923 | 0.216 | 0.352 | -- | 11.10 | 96.56 | 84.33 | -- | -- | -- |
| Senti Biosciences Inc | 1.28m | -86.11m | 17.16m | 48.00 | -- | 0.3056 | -- | 13.46 | -1.93 | -1.44 | 0.0285 | 1.23 | 0.0097 | -- | 2.94 | 26,562.50 | -65.33 | -- | -71.42 | -- | -- | -- | -6,753.80 | -- | -- | -- | 0.0018 | -- | -40.25 | -- | -67.94 | -- | -- | -- |
| Galecto Inc | 0.00 | -30.83m | 17.24m | 13.00 | -- | 0.6123 | -- | -- | -1.15 | -1.15 | 0.00 | 1.04 | 0.00 | -- | -- | 0.00 | -63.50 | -48.46 | -78.33 | -52.36 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 37.77 | -- | -- | -- |
| Minerva Neurosciences Inc | 0.00 | -31.60m | 17.34m | 9.00 | -- | -- | -- | -- | -4.48 | -4.48 | 0.00 | -5.23 | 0.00 | -- | -- | 0.00 | -61.90 | -49.89 | -65.32 | -52.39 | -- | -- | -- | -442.65 | -- | -- | -- | -- | -- | -- | 6.55 | -- | -- | -- |
| Alaunos Therapeutics Inc | 6.00k | -26.77m | 17.77m | 1.00 | -- | 3.71 | -- | 2,962.31 | -1.67 | -1.67 | 0.0004 | 0.2996 | 0.0002 | -- | 12.00 | 6,000.00 | -97.94 | -74.83 | -147.22 | -89.57 | -- | -- | -446,233.30 | -10,508.06 | -- | -19.25 | 0.00 | -- | -99.83 | -49.08 | 6.86 | -- | -15.56 | -- |
| Pharmacyte Biotech Inc | 0.00 | -14.82m | 18.09m | 2.00 | -- | 0.5812 | -- | -- | -1.64 | -1.64 | 0.00 | 5.74 | 0.00 | -- | -- | 0.00 | -1.53 | -13.35 | -1.62 | -13.70 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -1.81 | -- | -- | -- |
| Tonix Pharmaceuticals Holding Corp | 10.25m | -98.59m | 18.15m | 103.00 | -- | 0.1295 | -- | 1.77 | -5.54 | -5.54 | 0.2956 | 1.47 | 0.0652 | -- | -- | 99,514.56 | -62.71 | -59.46 | -70.20 | -65.92 | 37.55 | -- | -961.87 | -5,126.73 | 0.8666 | -- | 0.0767 | -- | -- | -- | 0.1874 | -- | 320.57 | -- |
| VBI Vaccines Inc | 9.41m | -83.99m | 18.32m | 131.00 | -- | -- | -- | 1.95 | -6.93 | -6.93 | 0.4818 | -0.2166 | 0.0923 | 1.40 | 37.05 | 71,839.70 | -81.40 | -46.58 | -171.57 | -58.62 | -24.06 | -277.46 | -881.79 | -2,755.98 | 0.2116 | -1.60 | 1.13 | -- | 702.40 | 20.94 | 17.18 | -- | -32.07 | -- |
| Talphera Inc | 651.00k | -14.31m | 18.35m | 15.00 | -- | 1.12 | -- | 28.19 | -0.8945 | -0.8863 | 0.0368 | 0.9612 | 0.0237 | -- | -- | 43,400.00 | -51.96 | -22.60 | -67.70 | -28.55 | -- | -- | -2,197.39 | -714.87 | -- | -- | 0.00 | -- | -- | -21.26 | -119.16 | -- | -34.33 | -- |
| Ibio Inc | 50.00k | -17.13m | 18.54m | 26.00 | -- | 0.7365 | -- | 370.82 | -13.10 | -17.09 | 0.0262 | 2.92 | 0.0011 | -- | 0.0065 | 1,923.08 | -36.24 | -28.09 | -67.39 | -32.63 | -- | -- | -34,258.00 | -1,467.30 | -- | -- | 0.3666 | -- | -100.00 | -- | 0.9764 | -- | 42.90 | -- |
| GlycoMimetics Inc | 10.00k | -37.28m | 18.62m | 35.00 | -- | 0.644 | -- | 1,862.38 | -0.5791 | -0.5791 | 0.0002 | 0.4486 | 0.0002 | -- | 0.0581 | 285.71 | -72.29 | -43.60 | -81.84 | -47.82 | -- | -- | -372,767.40 | -2,243.52 | -- | -- | 0.00 | -- | -86.67 | -- | 20.97 | -- | -29.82 | -- |
| Allied Corp | 21.51k | -9.00m | 18.62m | -- | -- | -- | -- | 865.82 | -0.0915 | -0.0915 | 0.0002 | -0.0711 | 0.0051 | 1.65 | 0.1441 | -- | -214.39 | -- | -- | -- | -6,919.57 | -- | -41,861.41 | -- | 0.0333 | -31.86 | -- | -- | -56.46 | -- | 31.30 | -- | -- | -- |
| Raphael Pharmaceutical Inc | 0.00 | -1.57m | 18.66m | 0.00 | -- | -- | -- | -- | -0.0929 | -0.0929 | 0.00 | -0.0055 | 0.00 | -- | -- | -- | -624.25 | -- | -- | -- | -- | -- | -- | -- | -- | -173.44 | -- | -- | -- | -- | 61.76 | -- | -- | -- |
| KALA BIO Inc | 0.00 | -39.55m | 18.67m | 43.00 | -- | 2.80 | -- | -- | -15.15 | -15.15 | 0.00 | 2.37 | 0.00 | -- | -- | 0.00 | -63.15 | -57.83 | -76.71 | -69.32 | -- | 57.06 | -- | -1,553.61 | -- | -12.26 | 0.8382 | -- | -100.00 | -- | 5.85 | -- | -17.31 | -- |
Data as of May 21 2024. Currency figures normalised to Alaunos Therapeutics Inc's reporting currency: US Dollar USD
13.68%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| MSD Partners LPas of 31 Mar 2024 | 1.01m | 6.31% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 624.14k | 3.90% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 222.35k | 1.39% |
| Geode Capital Management LLCas of 31 Mar 2024 | 150.42k | 0.94% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 50.33k | 0.31% |
| Securities America Advisors, Inc.as of 31 Mar 2024 | 33.50k | 0.21% |
| Commerce Bank (Investment Management)as of 31 Mar 2024 | 29.13k | 0.18% |
| Northern Trust Investments, Inc.(Investment Management)as of 31 Mar 2024 | 29.03k | 0.18% |
| Magnolia Capital Advisors LLCas of 31 Mar 2024 | 24.70k | 0.15% |
| Allred Capital Management LLCas of 31 Mar 2024 | 16.87k | 0.11% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
